EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms

Jean Bousquet iD, Bernardo Sousa-Pinto, Rafael José Vieira iD, Holger J Schünemann, Torsten Zuberbier iD, Antonio Bognanni iD, Alkis Togias, Boleslaw Samolinski, Arunas Valiulis, Sian Williams, Anna Bedbrook, Wienczyslawa Czarlewski und 48 weitere

Allergy · 2026-02 · 81 (2) · 427-453

DOI: 10.1111/all.70100 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Allergy, online erschienen am 21.11.2025. Verfasst von Jean Bousquet und 59 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berl…. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Asthma, Algorithms, Practice Guidelines as Topic. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, CINTESIS@RISE, Porto, Portugal, ARIA (Allergic Rhinitis and its Impact on Asthma), Montpellier, France.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines produced their first edition in 1999, with subsequent revisions in 2008, 2010, 2016 and 2019. A new iteration of ARIA—ARIA 2024–2025—in collaboration with EAACI is currently being developed, focusing on the management of allergic rhinitis. ARIA 2024–2025 follows the GRADE framework and is endorsed by the European Academy of Allergy and Clinical Immunology (EAACI). A set of approaches has been used to develop guideline questions, including surveying key opinion leaders and using artificial intelligence (AI)‐based tools to analyse web searches on allergic rhinitis and to generate questions. Each prioritised guideline question is assessed through an Evidence‐to‐Decision (EtD) framework. EtDs support the systematic and transparent formulation of recommendations, comprising 12 criteria for which the best available evidence should be sought. In the context of ARIA‐EAACI 2024–2025, such evidence is derived not only from randomised controlled trials but also—among others—from patient‐generated data sources that better reflect the affected individuals' perspectives. Moreover, ARIA‐EAACI 2024–2025 incorporates evidence on planetary health. Developed guideline recommendations will support the creation of digitalised decision algorithms and care pathways. This paper describes the methodology used to develop the person‐centred, digitally enabled and AI‐assisted ARIA‐EAACI 2024–2025. Among others, it describes (i) the development and prioritisation of guideline questions, (ii) sources of evidence for EtDs and (iii) the development of digitalised decision algorithms and care pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhinitis, AllergicAsthmaAlgorithmsPractice Guidelines as TopicDecision Making, SharedHumansEvidence-Based MedicineClinical Decision-MakingDisease Management

Stichwörter der Autor:innen

ENT (rhinitis, sinusitis, nasal polyps…)allergic rhinitisasthmaguidelines

Autor:innen und Institutionen

  • Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
  • ARIA (Allergic Rhinitis and Its Impact on Asthma), Montpellier, France.
  • MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
  • CINTESIS@RISE-Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Department of Health Research Methods, Evidence, and Impact & Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

ORCID-Profile: Jean Bousquet, Rafael José Vieira, Torsten Zuberbier, Antonio Bognanni, Maria Jose Torres, Mohamed H Shamji, Mário Morais-Almeida, G Walter Canonica, Leticia de Las Vecillas, Ludger Klimek, Olga Lourenço, Nikolaos G Papadopoulos, Marine Savouré, Sanna K Toppila-Salmi, Alvaro A Cruz, Mattia Giovannini, Tuomas Jartti, Miloš Jeseňák, Oliver Pfaar, Luo Zhang, Tari Haahtela, Ivan Cherrez-Ojeda, Arzu Yorgancioglu

Förderung

  • World Health Organization
  • CINTESIS@RISE, Porto, Portugal
  • ARIA (Allergic Rhinitis and its Impact on Asthma), Montpellier, France
  • Fraunhofer-Institut für Translationale Medizin und Pharmakologie

Zitieren

APA

Bousquet, J., Sousa-Pinto, B., Vieira, R. J., Schünemann, H. J., Zuberbier, T., Bognanni, A., Togias, A., Samolinski, B., Valiulis, A., Williams, S., Bedbrook, A., Czarlewski, W., Torres, M. J., Shamji, M. H., Morais-Almeida, M., Canonica, G. W., Vecillas, L. L., Dykewicz, M. S., Jacomelli, C., …, & Abdullah, B. (2026). Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms. Allergy, 81(2), 427-453. https://doi.org/10.1111/all.70100

Vancouver

Bousquet J, Sousa-Pinto B, Vieira RJ, Schünemann HJ, Zuberbier T, Bognanni A, et al. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms. Allergy. 2026;81(2):427-453. doi:10.1111/all.70100

BibTeX
@article{Bousquet2026,
  author = {Bousquet, Jean and Sousa-Pinto, Bernardo and Vieira, Rafael José and Schünemann, Holger J and Zuberbier, Torsten and Bognanni, Antonio and Togias, Alkis and Samolinski, Boleslaw and Valiulis, Arunas and Williams, Sian and Bedbrook, Anna and Czarlewski, Wienczyslawa and Torres, Maria Jose and Shamji, Mohamed H and Morais-Almeida, Mário and Canonica, G Walter and Vecillas, Leticia de Las and Dykewicz, Mark S and Jacomelli, Cristina and Klimek, Ludger and Leemann, Lucas and Lourenço, Olga and Palamarchuk, Yuliia and Papadopoulos, Nikolaos G and Pereira, Ana Margarida and Savouré, Marine and Toppila-Salmi, Sanna K and Ventura, Maria Teresa and Yepes-Nuñez, Juan Jose and Cruz, Alvaro A and Ciprandi, Giorgio and Gemicioglu, Bilun and Giovannini, Mattia and Gradauskiene, Brigita and Jartti, Tuomas and Jeseňák, Miloš and Kuna, Piotr and Kvedariene, Violeta and Larenas-Linnemann, Désirée E and Latiff, Amir H A and Mohammad, Yousser and Ohta, Ken and Mahesh, Padukudru A and Pali-Schöll, Isabella and Pfaar, Oliver and Regateiro, Frederico S and Roche, Nicolas and Sofiev, Mikhail and Taborda-Barata, Luís and Ulrik, Charlotte Suppli and Rostan, Marylin Valentin and Viegi, Giovanni and Zhang, Luo and Antó, Josep M and Haahtela, Tari and Cherrez-Ojeda, Ivan and Ivancevich, Juan Carlos and Khaltaev, Nikolai and Yorgancioglu, Arzu and Abdullah, Baharudin},
  title = {Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms},
  journal = {Allergy},
  year = {2026},
  volume = {81},
  number = {2},
  pages = {427--453},
  doi = {10.1111/all.70100}
}
Kostenlos starten →